AQP4 and myeloid sarcoma: Therefore, for the differentiation of NMO from classic MS, RRMS, and other neuroimmune disorders, it is crucial to use live cell or tissue-based assays employing native AQP4, rather than assays utilizing peptides selected from extracellular or intracellular loops.